Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer.

The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer. Oncologist. 2011; 16(11):1498-507.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.